Yayınlar & Eserler

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Use of volumetric CT scanning to predict tumor staging and survival in pancreatic cancer patients that are to be administered curative resection

ŞENGÜL SAMANCI N. , ÇELİK E. , BAĞCILAR Ö. , TUTAR O. , SAMANCI C. , VELİDEDEOĞLU M. , et al.
JOURNAL OF SURGICAL ONCOLOGY, 2021 (SCI İndekslerine Giren Dergi) identifier identifier

Independent prognostic value of inflammation in metastatic pancreatic cancer.

Oksuzoglu B., Esin E., Koksoy E. B. , Demirci N. S. , Sendur M. A. N. , Dede I., et al.
JOURNAL OF CLINICAL ONCOLOGY, cilt.36, sa.15, 2018 (SCI İndekslerine Giren Dergi) identifier

Preoperative platelet-to-lymphocyte ratio is a predictor of prognosis in patients with ampullary carcinoma

Demirci N. S. , Ozdemir N. Y. , Erdem G. U. , Bozkaya Y., Yazici O., Zengin N.
BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, cilt.119, sa.3, ss.180-186, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Queries for the article entitled "Predictors for extensive nodal involvement in breast cancer patients with axillary lymph node metastases"

Erdem G. U. , Sahin S., Karatas F., Aytekin A., Demirci N. S. , Yazilitas D.
BREAST, cilt.36, ss.104-105, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?

Demirci N. S. , Dogan M., Erdem G. U. , Kacar S., Turhan T., KILIÇKAP S., et al.
SAUDI JOURNAL OF GASTROENTEROLOGY, cilt.23, sa.3, ss.183-189, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer.

Erdem G. U. , Altundag K., Ozdemir N. Y. , Sahin S., Demirci N. S. , Karatas F., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.22, ss.365-376, 2017 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study

Demirci N. S. , AKSOY S., Ozdemir N. Y. , Erdem G. U. , Ozcelik M., Tanrikulu E., et al.
CURRENT MEDICAL RESEARCH AND OPINION, cilt.33, sa.3, ss.401-407, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach

Bozkaya Y., Erdem G. U. , Ozdemir N. Y. , Demirci N. S. , Hocazade C., Yazici O., et al.
CURRENT MEDICAL RESEARCH AND OPINION, cilt.33, sa.1, ss.109-116, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

The efficacy of modified docetaxel-cisplatin-5-fluorouracil regimen as first-line treatment in patients with alpha-fetoprotein producing gastric carcinoma

Bozkaya Y., Dogan M., Yazici O., Erdem G. U. , Demirci N. S. , Zengin N.
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, cilt.17, sa.2, ss.138-143, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Prognostic Effect of Symptomatic and Asymptomatic Venous Thromboembolism in Patients with Gastric Cancer

Bozkaya Y., Ozdemir N., Demirci N. S. , Erdem G. U. , Yazici O., Arslan S., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.27, sa.2, ss.100-109, 2017 (SCI İndekslerine Giren Dergi) identifier identifier

The clinical and pathological features affecting the time of relapse in patients with early stage colorectal cancer

Yazilitas D., Ozdemir N., Yazici O., Hocazade C., Demirci N. S. , Zengin N.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.12, sa.4, ss.1257-1260, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology

Odabas H., Ulas A., Aydin K., İNANÇ M., Aksoy A., Yazilitas D., et al.
TUMOR BIOLOGY, cilt.36, sa.12, ss.9641-9648, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

A rare case: Hallucination associated with pazopanib

Demirci N. S. , Erdem G. U. , Dogan M., Ozdemir N. Y. , Zengin N.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.11, sa.4, ss.961-962, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Rectal Cancer With Metastasis to the Face

Yazilitas D., Dogan M., Ileri A. B. , Ozdemir N., Demirci N. S. , Zengin N.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, cilt.25, sa.2, ss.145-147, 2015 (SCI İndekslerine Giren Dergi) identifier identifier

Can targeted programmed death-1 antibody be a new treatment approach in breast cancer.

Sendur M. A. N. , Aksoy S., Demirci S. , Ozdemir N. Y. , Zengin N., Altundag K.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, cilt.19, ss.584, 2014 (SCI Expanded İndekslerine Giren Dergi) identifier identifier

IS SECOND LINE SYSTEMIC CHEMOTHERAPY BENEFICIAL IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)? : A MULTICENTER DATA EVALUATION OF ANATOLIAN SOCIETY OF MEDICAL ONCOLOGY (ASMO)

Odabas H., Ulas A., Aydin K., İNANÇ M., Aksoy A., Yazilitas D., et al.
JOURNAL OF THORACIC ONCOLOGY, cilt.8, 2013 (SCI İndekslerine Giren Dergi) identifier

Diğer Dergilerde Yayınlanan Makaleler

The Determinants of Profitability in Manufacturing Industry Sector: Panel Data Analysis with CBRT Sectoral Balance Sheets (1996-2015)

Demirci N. S.
EGE ACADEMIC REVIEW, cilt.17, sa.3, ss.381-393, 2017 (ESCI İndekslerine Giren Dergi) identifier

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Modified epirubicin and oxaliplatin plus capecitabine (EOX) Regimen as second-line therapy after failure of modified docetaxel and cisplatin plus fuorouracil (DCF) regimen in advanced gastric cancer

Bozkaya Y., Yazici O., Ozdemir N., Erdem G. U. , Demirci N. S. , Zengin N.
42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, İspanya, 8 - 12 Eylül 2017, cilt.28 identifier

Plasma caveolin-1 level: A prognostic marker for pancreatic cancer.

Demirci N. S. , Dogan M., Erdem G. U. , Kacar S., Turhan T., Yilmaz F. M. , et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 identifier

Modified docetaxel, cisplatin and fluorouracil therapy as a first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study.

Demirci N. S. , Aksoy S., Ozdemir N., Babacan T., Erdem G. U. , Bozkaya Y., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 identifier

Clinicopathologic analysis and prognostic factors for survival in early stage patients with ampullary carcinoma.

Ozdemir N., Demirci N. S. , Yuksel S., Erdem G. U. , Odabas H., Boruban M. C. , et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 identifier

Comparative study of receptor expression diversity between primary and recurrent lesions in patients with metastatic breast cancer.

Erdem G. U. , Ozdemir N., Sahin S., Demirci N. S. , Karatas F., Bozkaya Y., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 identifier

Effect of adding taxane to platin-5-fluorouracil combination on survival in elderly patients with advanced gastric cancer: A retrospective-multicenter study.

Gunaldi M., Kose F., Demirci N. S. , Gundur S., Ozdemir N., Kocoglu H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 3 - 07 Haziran 2016, cilt.34 identifier

The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen

Yazici O., Ozdemir N., EREL Ö., Demirci N. S. , AKSOY S., ŞENDUR M. A. N. , et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51 identifier

The importance of thiol/disulphide homeostasis in patients with advanced colorectal cancer receiving modified fluorouracil and leucoverin plus oxaliplatin (mFOLFOX) regimen

Yazici O., Dogan M., EREL Ö., Bozkaya Y., Ozdemir N., Demirci N. S. , et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51 identifier

Operated and early stage ampulla vateri tumours: Prognostic assessment

Yildirim N., Mulazimoglu E., Yuksel S., Demirci N. S. , Erdem G. U. , Odabas H., et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51 identifier

The effect of body mass index on prognosis and survival of ER(-) and PR(+) nonmetastatic breast cancer patients: Single institute experience.

Dogan M., Erdem G. U. , Demirci N. S. , Zengin N.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33 identifier